BNO 5.26% 20.0¢ bionomics limited

Obviously the share price at the moment is sub-optimal. I agree...

  1. 590 Posts.
    lightbulb Created with Sketch. 4

    Obviously the share price at the moment is sub-optimal. I agree that this trial is going to be more difficult than previous mostly because it ptsd but also because of the additional constraints placed on the trial by the US. I'm not so sure about people knowing the outcome already. FWIW the share price trailed down in much the same pattern before the successful GAD trial. The skeptic in me says that the agitation trial has been added on as a just in case. But I think it's too early to bet against Momma Rathjen.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.